Key facts
- Notable investors include Sound Invest.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Synlotic
- ·The full record, as it builds
Funding rounds
No funding rounds for Synlotic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Synlotic
Developer of biotechnological processes medicines intended for pharmaceutical, cosmetic, and industrial applications. The company offers synthetic biology methods, enzyme gene mining, enzyme-directed modification, microbial cell factory construction, biocatalysis, and fermentation technologies, laboratories, customized compound development, and integration into fields such as natural flavor synthesis, medical intermediates, diagnostic reagents, and bio-based materials, enabling healthcare, cosmetics, and industrial markets to achieve sustainable production, improved efficiency, and reliable access to advanced biotechnological solutions.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Website
- synlotic.cn/
- Ownership
- Privately Held (backing)
Synlotic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Synlotic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Synlotic in its N-PORT filings yet. We sweep new filings monthly.